R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well R-(-)-gossypol acetic acid works in treating
patients with recurrent extensive-stage small cell lung cancer. Drugs used in chemotherapy,
such as R-(-)-gossypol acetic acid, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing.